TY  -  
T1  - Patient Preferences for Multiple Myeloma Treatments : A Multinational Qualitative Study 
SN  -  /  
UR  - http://hdl.handle.net/10138/334482 
T3  -  
A1  - Janssens, Rosanne; Lang, Tamika; Vallejo, Ana; Galinsky, Jayne; Plate, Ananda; Morgan, Kate; Cabezudo, Elena; Silvennoinen, Raija; Coriu, Daniel; Badelita, Sorina; Irimia, Ruxandra; Anttonen, Minna; Manninen, Riikka-Leena; Schoefs, Elise; Vandebroek, Martina; Vanhellemont, Anneleen; Delforge, Michel; Stevens, Hilde; Simoens, Steven; Huys, Isabelle 
A2  -  
PB  -  
Y1  - 2021 
LA  - eng 
AB  - Background: Investigational and marketed drugs for the treatment of multiple myeloma (MM) are associated with a range of characteristics and uncertainties regarding long term side-effects and efficacy. This raises questions about what matters most to patients living with this disease. This study aimed to understand which characteristics MM patients find most important, and hence should be included as attributes and levels in a subsequent quantitative preference survey among MM patients. Methods:... 
VO  -  
IS  -  
SP  -  
OP  -  
KW  - multiple myeloma; patient preferences; nominal group technique; qualitative research; attributes; drug development; regulatory benefit-risk assessment; health technology assessment; DISCRETE-CHOICE EXPERIMENTS; DATA SATURATION; NOMINAL GROUP; 3122 Cancers 
N1  -   
PP  -  
ER  -